In the evolving landscape of diabetes management, novel treatments like semaglutide and retatrutide are gaining traction. These agents, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist group, offer https://tamzinafjr813346.uzblog.net/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management-52636757